Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 342RC | IM |
Priorix was mistakenly given in the deltoid muscle rather than subcutaneously; This non-serious case was reported by a nurse via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 18-year-old male patient who received MMR (Priorix) (batch number 342RC, expiry date 01-MAY-2025) for prophylaxis. On 15-JAN-2025, the patient received Priorix (intramuscular, unknown deltoid). On 15-JAN-2025, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: Priorix was mistakenly given in the deltoid muscle rather than subcutaneously). The outcome of the subcutaneous injection formulation administered by other route was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 15-JAN-2025 The reporter was the Healthcare Professional. Priorix was mistakenly given in the deltoid muscle rather than subcutaneously which led to Subcutaneous injection formulation administered by other route. Nothing else was reported.